Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.290
+0.040 (16.05%)
At close: Nov 20, 2024, 4:00 PM
0.268
-0.022 (-7.59%)
Pre-market: Nov 21, 2024, 8:03 AM EST
Aptevo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5 | 3 | 12 | 39 | 160 | 30 | |
| Market Cap Growth | -36.45% | -71.13% | -69.36% | -75.98% | 441.52% | 2.78% | |
| Enterprise Value | 2 | -10 | -0 | 6 | 164 | 36 | |
| Last Close Price | 0.29 | 7.96 | 102.08 | 346.28 | 1612.60 | 403.17 | |
| PE Ratio | - | - | 1.48 | - | - | - | |
| PS Ratio | - | - | 3.79 | 3.14 | 37.24 | - | |
| PB Ratio | 1.12 | 0.28 | 0.66 | 31.70 | 9.67 | 2.50 | |
| P/TBV Ratio | 0.55 | 0.28 | 0.66 | 31.70 | 9.67 | 2.50 | |
| EV/Sales Ratio | - | - | - | 0.47 | 38.03 | - | |
| Debt / Equity Ratio | 1.09 | 0.50 | 0.55 | 13.75 | 1.65 | 1.96 | |
| Asset Turnover | - | - | 0.07 | 0.22 | 0.08 | - | |
| Quick Ratio | 1.32 | 2.34 | 2.89 | 1.40 | 2.91 | 0.33 | |
| Current Ratio | 1.70 | 2.64 | 3.15 | 1.51 | 3.25 | 0.78 | |
| Return on Equity (ROE) | -250.96% | -123.53% | 73.10% | -330.24% | -217.49% | -203.86% | |
| Return on Assets (ROA) | -72.75% | -61.12% | -39.42% | -24.29% | -32.13% | -42.35% | |
| Return on Capital (ROIC) | -104.10% | -78.08% | -78.06% | -43.19% | -43.48% | -60.44% | |
| Earnings Yield | -441.85% | -510.58% | 67.95% | -73.82% | -11.06% | -136.49% | |
| FCF Yield | -433.62% | -343.98% | -178.21% | -58.09% | -18.32% | -143.53% | |
| Buyback Yield / Dilution | -1417.44% | -139.76% | -8.85% | -38.25% | -16.25% | -81.50% | |
| Total Shareholder Return | -1417.44% | -139.76% | -8.85% | -38.25% | -16.25% | -81.50% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.